Profile
Ei Yamada is currently Chief Executive Officer at AnGes Euro Ltd. since 2002, Chief Executive Officer at AnGes USA, Inc. since 2014, Chief Executive Officer at EmendoBio, Inc., President & Representative Director at AnGes, Inc. since 2002, Outside Director at MyBiotics Pharma Ltd. since 2018, and Director at Emendo Biotherapeutics, Inc. since 2020.
Former roles include Director at Takara Bio, Inc.
Ei Yamada active positions
| Companies | Position | Start |
|---|---|---|
| ANGES, INC. | President | 2002-08-31 |
AnGes Euro Ltd. | Chief Executive Officer | 2002-05-31 |
AnGes USA, Inc.
AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines | Chief Executive Officer | 2014-02-28 |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Director/Board Member | 2019-12-31 |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Director/Board Member | 2018-11-30 |
EmendoBio, Inc.
EmendoBio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene editing tools for genetic disorders | Chief Executive Officer | - |
Former positions of Ei Yamada
| Companies | Position | End |
|---|---|---|
| TAKARA BIO INC. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Takara Bio, Inc.
Takara Bio, Inc. Medical SpecialtiesHealth Technology Develops, produces, and markets biological products | Health Technology |
AnGes, Inc.
AnGes, Inc. Pharmaceuticals: GenericHealth Technology Manufactures gene pharmaceutical medicines | Health Technology |
AnGes Euro Ltd. | |
AnGes USA, Inc.
AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines | Health Technology |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Health Technology |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
EmendoBio, Inc.
EmendoBio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene editing tools for genetic disorders | Commercial Services |
- Stock Market
- Insiders
- Ei Yamada
















